Medpace Holdings, Inc.

Medpace Holdings, Inc. is a clinical contract research organization that provides outsourced clinical development services across Phase I through Phase IV trials. Its offerings serve biotechnology, pharmaceutical, and medical device companies, focusing especially on small and mid-sized biopharmaceutical developers. The company provides medical study design, trial execution via its proprietary ClinTrak software, patient recruitment, regulatory compliance, biometrics, pharmacovigilance, and quality assurance. Additionally, it provides specialized laboratory support through central, bioanalytical, and core imaging and cardiovascular facilities, alongside research clinics that evaluate therapeutics in healthy volunteers and targeted patient groups.

Medpace maintains an international presence with approximately 6,200 employees distributed across 46 countries worldwide. Its laboratory network spans locations in Cincinnati, Ohio; Leuven, Belgium; Shanghai, China; and Singapore. In addition, the company's dedicated bioanalytical laboratory and early-phase clinical trial facilities operate from its central research campus located in Cincinnati, Ohio, where key corporate activities are centered.

Summary of the business section of Medpace's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025 we had approximately 6,200 employees located across 46 countries.”